Evaluation of the Efficacy and Safety of THRV-1268 in Participants With Long QT Syndrome Type 2 (LQTS2) and Type 3 (LQTS3)
Evaluation of the Efficacy and Safety of THRV-1268 in Participants With Long QT Syndrome Type 2 (LQTS2) and Type 3 (LQTS3)
Recruiting · NCT07277582 · Registry updated 2026-09-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluation of the Efficacy and Safety of THRV-1268 in Participants With Long QT Syndrome Type 2 (LQTS2) and Type 3 (LQTS3) | Arrhythmias, Cardiac, Cardiac Conduction System Disease, Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiovascular disorder, congenital heart disease, heart disorder | Recruiting | Phase 2 / Phase 3 | 2026-09-21 | NCT07277582 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Thryv Therapeutics, Inc. | 2 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Heart Center Clinical Research Program | MGH | Boston | United States | 1 |
| Honor Health Research and Innovation Institute | Scottsdale | United States | 2 |
| Mayo Clinic | Rochester | United States | 664 |
| NYU Langone Health | New York | United States | 403 |
| Oregon Health & Science University | Portland | United States | 261 |
| University of California San Francisco | San Francisco | United States | 144 |
| University of Illinois Chicago | Chicago | United States | 41 |
| University of Michigan | Arbor | United States | 1 |
| Wilmington Health | Wilmington | United States | 6 |